{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:15:48Z","timestamp":1794244548384,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"41","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Special Fund for the Construction of Innovative Provinces in Hunan Province"},{"name":"the National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,10,28]]},"DOI":"10.1038\/s41388-026-03967-7","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T18:05:57Z","timestamp":1788026757000},"page":"4454-4470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DHCR24+ tumor epithelial cells drive cisplatin resistance in bladder cancer by enhancing cholesterol metabolism to activate lipid raft-associated MAPK signaling"],"prefix":"10.1038","volume":"45","author":[{"given":"Yuanqiao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8721-4488","authenticated-orcid":false,"given":"Zhuo","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangmin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-0252","authenticated-orcid":false,"given":"Yinhuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6798-0870","authenticated-orcid":false,"given":"Bin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9724-5802","authenticated-orcid":false,"given":"Xueqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"3967_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"key":"3967_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202502774","volume":"12","author":"W Xu","year":"2025","unstructured":"Xu W, Liang T, Fang H, Fu L, Deng D, Tan X, et al. Single-cell RNA sequencing identifies MMP11(+) cancer-associated fibroblasts as drivers of angiogenesis and bladder cancer progression. Adv Sci. 2025;12:e02774.","journal-title":"Adv Sci"},{"key":"3967_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, et al. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat. 2023;68:100938.","journal-title":"Drug Resist Updat"},{"key":"3967_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414558","volume":"12","author":"H Zhao","year":"2025","unstructured":"Zhao H, Lin N, Ho VWS, Liu K, Chen X, Wu H, et al. Patient-derived bladder cancer organoids as a valuable tool for understanding tumor biology and developing personalized treatment. Adv Sci. 2025;12:e2414558.","journal-title":"Adv Sci"},{"key":"3967_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1585727","volume":"16","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Xing Z, Zhao Y, Xu H, Liu R, Yang T, et al. Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer. Front Immunol. 2025;16:1585727.","journal-title":"Front Immunol"},{"key":"3967_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408599","volume":"12","author":"M Deng","year":"2025","unstructured":"Deng M, Zhou Z, Chen J, Li X, Liu Z, Ye J, et al. Enhanced oxidative phosphorylation driven by TACO1 mitochondrial translocation promotes stemness and cisplatin resistance in bladder cancer. Adv Sci. 2025;12:e2408599.","journal-title":"Adv Sci"},{"key":"3967_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","volume":"14","author":"Y Lei","year":"2021","unstructured":"Lei Y, Tang R, Xu J, Wang W, Zhang B, Liu J, et al. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol. 2021;14:91.","journal-title":"J Hematol Oncol"},{"key":"3967_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012;21:297\u2013308.","journal-title":"Cancer Cell"},{"key":"3967_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34:355\u201377.","journal-title":"Cell Metab"},{"key":"3967_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206878","volume":"10","author":"X Zhao","year":"2023","unstructured":"Zhao X, Guo B, Sun W, Yu J, Cui L. Targeting squalene epoxidase confers metabolic vulnerability and overcomes chemoresistance in HNSCC. Adv Sci. 2023;10:e2206878.","journal-title":"Adv Sci"},{"key":"3967_CR11","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1021\/acs.biochem.6b00342","volume":"55","author":"NM Cerqueira","year":"2016","unstructured":"Cerqueira NM, Oliveira EF, Gesto DS, Santos-Martins D, Moreira C, Moorthy HN, et al. Cholesterol biosynthesis: a mechanistic overview. Biochemistry. 2016;55:5483\u2013506.","journal-title":"Biochemistry"},{"key":"3967_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-020-2911-7","volume":"588","author":"X Liu","year":"2020","unstructured":"Liu X, Bao X, Hu M, Chang H, Jiao M, Cheng J, et al. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. Nature. 2020;588:693\u20138.","journal-title":"Nature"},{"key":"3967_CR13","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1158\/0008-5472.CAN-23-3703","volume":"84","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, Luo Y, Zhao K, Liu S, Wu K, Wu Y, et al. m6A-mediated induction of 7-dehydrocholesterol reductase stimulates cholesterol synthesis and cAMP signaling to promote bladder cancer metastasis. Cancer Res. 2024;84:3402\u201318.","journal-title":"Cancer Res"},{"key":"3967_CR14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2520427123","volume":"123","author":"L Tan","year":"2026","unstructured":"Tan L, Zhou H, Zhang B, Kwong DLW, Jia Y, Huang J, et al. Multiomics identifies a cholesterol-TFEB-PLD3-TLR9 axis driving immunosuppressive tumor-associated macrophage polarization in esophageal squamous cell carcinoma. Proc Natl Acad Sci USA. 2026;123:e2520427123.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3967_CR15","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2024.01.005","volume":"36","author":"C Hu","year":"2024","unstructured":"Hu C, Qiao W, Li X, Ning ZK, Liu J, Dalangood S, et al. Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8(\u2009+\u2009)T cells. Cell Metab. 2024;36:630\u201347.e638.","journal-title":"Cell Metab"},{"key":"3967_CR16","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1016\/j.csbj.2022.07.030","volume":"20","author":"L Tang","year":"2022","unstructured":"Tang L, Wei R, Chen R, Fan G, Zhou J, Qi Z, et al. Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma. Comput Struct Biotechnol J. 2022;20:4402\u201314.","journal-title":"Comput Struct Biotechnol J"},{"key":"3967_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/cns.70833","volume":"32","author":"R Sun","year":"2026","unstructured":"Sun R, Wang X, Wang Z, Li C, Shao Q, Liu X, et al. Transcriptomic insights into Alzheimer\u2019s disease: differentially expressed genes and cholesterol metabolism. CNS Neurosci Ther. 2026;32:e70833.","journal-title":"CNS Neurosci Ther"},{"key":"3967_CR18","first-page":"40.","volume":"15","author":"M Xu","year":"2025","unstructured":"Xu M, Hu J, Pu L, Liu J, Yang Y, Li Q, et al. Multi-omics integration identifies the cholesterol metabolic enzyme DHCR24 as a key driver in breast cancer. Biology (Basel). 2025;15:40.","journal-title":"Biology (Basel)"},{"key":"3967_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3892\/ol.2025.15131","volume":"30","author":"Z Wang","year":"2025","unstructured":"Wang Z, Mao J, Zhang Y, Yang W, Sun D, Lu Z, et al. Pan-cancer analysis reveals the potential role of DHCR24 in bladder cancer via interactions with HRAS to facilitate cholesterol synthesis. Oncol Lett. 2025;30:385.","journal-title":"Oncol Lett"},{"key":"3967_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrm.2017.16","volume":"18","author":"E Sezgin","year":"2017","unstructured":"Sezgin E, Levental I, Mayor S, Eggeling C. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. 2017;18:361\u201374.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3967_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01547-3","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan Z, Wang K, Wang X, Jia Z, Yang Y, Duan Y, et al. Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR\/Src\/Erk\/SP1 signaling-mediated ERRalpha re-expression. Mol Cancer. 2022;21:77.","journal-title":"Mol Cancer"},{"key":"3967_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2023.04.092","volume":"663","author":"R Nakajima","year":"2023","unstructured":"Nakajima R, Deguchi R, Komori H, Zhao L, Zhou Y, Shirasawa M, et al. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F. Biochem Biophys Res Commun. 2023;663:154\u201362.","journal-title":"Biochem Biophys Res Commun"},{"key":"3967_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ceb.2007.10.006","volume":"19","author":"PJ Iaquinta","year":"2007","unstructured":"Iaquinta PJ, Lees JA. Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol. 2007;19:649\u201357.","journal-title":"Curr Opin Cell Biol"},{"key":"3967_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrm714","volume":"3","author":"JM Trimarchi","year":"2002","unstructured":"Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol. 2002;3:11\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3967_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.143543","volume":"310","author":"G Ju","year":"2025","unstructured":"Ju G, Lin Q, Lu L, Lin Z, Huang D, Lin Y, et al. TFDP1 drives triple-negative breast cancer development through senescence suppression and serves as a therapeutic target for topotecan. Int J Biol Macromol. 2025;310:143543.","journal-title":"Int J Biol Macromol"},{"key":"3967_CR26","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comperat","year":"2022","unstructured":"Comperat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet. 2022;400:1712\u201321.","journal-title":"Lancet"},{"key":"3967_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110941","volume":"302","author":"P Lin","year":"2026","unstructured":"Lin P, Xing Z, Hong Y, Xu H, Shao S, Luo L, et al. Integrin beta4 drives immune evasion and therapeutic resistance to PD-1 blockade in bladder cancer via MEK\/ERK signaling. J Biol Chem. 2026;302:110941.","journal-title":"J Biol Chem"},{"key":"3967_CR28","doi-asserted-by":"publisher","first-page":"eabq4722.","DOI":"10.1126\/sciadv.abq4722","volume":"8","author":"Q Wang","year":"2022","unstructured":"Wang Q, Cao Y, Shen L, Xiao T, Cao R, Wei S, et al. Regulation of PD-L1 through direct binding of cholesterol to CRAC motifs. Sci Adv. 2022;8:eabq4722.","journal-title":"Sci Adv"},{"key":"3967_CR29","doi-asserted-by":"publisher","first-page":"46.","DOI":"10.1186\/s12943-025-02560-y","volume":"25","author":"A Du","year":"2026","unstructured":"Du A, Zhou Y, Deng X, Yuan D, Li K, Luo Y, et al. DCLK1 drives malignant progression and chemoresistance of bladder cancer by deubiquitinating HDAC6. Mol Cancer. 2026;25:46.","journal-title":"Mol Cancer"},{"key":"3967_CR30","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1038\/s41416-026-03364-7","volume":"134","author":"Z Xing","year":"2026","unstructured":"Xing Z, Xu H, Lin P, Hong Y, Shao S, Yang T, et al. ITGB4 up-regulated by STAT3 reduces the sensitivity of bladder cancer to cisplatin by suppressing p53. Br J Cancer. 2026;134:1704\u201315.","journal-title":"Br J Cancer"},{"key":"3967_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/ijc.33970","volume":"151","author":"M Dianatinasab","year":"2022","unstructured":"Dianatinasab M, Wesselius A, Salehi-Abargouei A, Yu EYW, Fararouei M, Brinkman M, et al. Dietary fats and their sources in association with the risk of bladder cancer: a pooled analysis of 11 prospective cohort studies. Int J Cancer. 2022;151:44\u201355.","journal-title":"Int J Cancer"},{"key":"3967_CR32","doi-asserted-by":"publisher","first-page":"e28125","DOI":"10.1097\/MD.0000000000028125","volume":"100","author":"HJ Shih","year":"2021","unstructured":"Shih HJ, Lin KH, Wen YC, Fan YC, Tsai PS, Huang CJ. Increased risk of bladder cancer in young adult men with hyperlipidemia: a population-based cohort study. Medicine. 2021;100:e28125.","journal-title":"Medicine"},{"key":"3967_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116530","volume":"44","author":"X Li","year":"2025","unstructured":"Li X, Sun Z, Zeng R, Liu R, Lin P, Xing Z, et al. Diet-metabolism-transcription axis modulates the sensitivity to CDK4\/6 inhibitors through RB1 in prostate cancer. Cell Rep. 2025;44:116530.","journal-title":"Cell Rep"},{"key":"3967_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115545","volume":"44","author":"Z Xing","year":"2025","unstructured":"Xing Z, Yang T, Li X, Xu H, Hong Y, Shao S, et al. High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy. Cell Rep. 2025;44:115545.","journal-title":"Cell Rep"},{"key":"3967_CR35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3967_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23:27\u201347.","journal-title":"Cell Metab"},{"key":"3967_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115907","volume":"218","author":"J Lu","year":"2023","unstructured":"Lu J, Chen S, Bai X, Liao M, Qiu Y, Zheng LL, et al. Targeting cholesterol metabolism in cancer: from molecular mechanisms to therapeutic implications. Biochem Pharmacol. 2023;218:115907.","journal-title":"Biochem Pharmacol"},{"key":"3967_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1158\/2159-8290.CD-24-0866","volume":"15","author":"X Wang","year":"2025","unstructured":"Wang X, Lee D, Xu H, Sui Y, Meisenhelder J, Hunter T. PIN1 prolyl isomerase promotes initiation and progression of bladder cancer through the SREBP2-mediated cholesterol biosynthesis pathway. Cancer Discov. 2025;15:633\u201355.","journal-title":"Cancer Discov"},{"key":"3967_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-025-03621-2","volume":"45","author":"M Li","year":"2025","unstructured":"Li M, Liu T, Shi J, Zhou F, Deng Z, Luo Y, et al. USP43 promotes gemcitabine resistance by regulating cholesterol homeostasis through E2F1 stabilization in bladder cancer. J Exp Clin Cancer Res. 2025;45:23.","journal-title":"J Exp Clin Cancer Res"},{"key":"3967_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114962","volume":"43","author":"M Wu","year":"2024","unstructured":"Wu M, Zhou X, Zhou X, Wang G, Zeng Y, Li J, et al. ZDHHC3-mediated SCAP S-acylation promotes cholesterol biosynthesis and tumor immune escape in hepatocellular carcinoma. Cell Rep. 2024;43:114962.","journal-title":"Cell Rep"},{"key":"3967_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13046-021-02041-2","volume":"40","author":"W Jiang","year":"2021","unstructured":"Jiang W, Hu JW, He XR, Jin WL, He XY. Statins: a repurposed drug to fight cancer. J Exp Clin Cancer Res. 2021;40:241.","journal-title":"J Exp Clin Cancer Res"},{"key":"3967_CR42","doi-asserted-by":"publisher","first-page":"6648","DOI":"10.3390\/curroncol30070488","volume":"30","author":"P Symvoulidis","year":"2023","unstructured":"Symvoulidis P, Tsioutis C, Zamboglou C, Agouridis AP. The effect of statins on the incidence and prognosis of bladder cancer: a systematic review and meta-analysis. Curr Oncol. 2023;30:6648\u201365.","journal-title":"Curr Oncol"},{"key":"3967_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1194\/jlr.M043257","volume":"55","author":"W Luu","year":"2014","unstructured":"Luu W, Zerenturk EJ, Kristiana I, Bucknall MP, Sharpe LJ, Brown AJ. Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis. J Lipid Res. 2014;55:410\u201320.","journal-title":"J Lipid Res"},{"key":"3967_CR44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ebiom.2015.05.020","volume":"2","author":"SL Chan","year":"2015","unstructured":"Chan SL, Chan AW. Development of serum DHCR24 antibody as a marker for hepatocellular carcinoma: the end of the beginning. EBioMedicine. 2015;2:497\u20138.","journal-title":"EBioMedicine"},{"key":"3967_CR45","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.2353\/ajpath.2009.080868","volume":"175","author":"TL Romanuik","year":"2009","unstructured":"Romanuik TL, Ueda T, Le N, Haile S, Yong TM, Thomson T, et al. Novel biomarkers for prostate cancer including noncoding transcripts. Am J Pathol. 2009;175:2264\u201376.","journal-title":"Am J Pathol"},{"key":"3967_CR46","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1111\/cas.14587","volume":"111","author":"T Qiu","year":"2020","unstructured":"Qiu T, Cao J, Chen W, Wang J, Wang Y, Zhao L, et al. 24-Dehydrocholesterol reductase promotes the growth of breast cancer stem-like cells through the Hedgehog pathway. Cancer Sci. 2020;111:3653\u201364.","journal-title":"Cancer Sci"},{"key":"3967_CR47","doi-asserted-by":"publisher","first-page":"S538","DOI":"10.1245\/s10434-014-3560-6","volume":"21","author":"GT Lee","year":"2014","unstructured":"Lee GT, Ha YS, Jung YS, Moon SK, Kang HW, Lee OJ, et al. DHCR24 is an independent predictor of progression in patients with non-muscle-invasive urothelial carcinoma, and its functional role is involved in the aggressive properties of urothelial carcinoma cells. Ann Surg Oncol. 2014;21:S538\u2013545.","journal-title":"Ann Surg Oncol"},{"key":"3967_CR48","doi-asserted-by":"publisher","first-page":"e11830","DOI":"10.1097\/MD.0000000000011830","volume":"97","author":"XP Liu","year":"2018","unstructured":"Liu XP, Yin XH, Meng XY, Yan XH, Cao Y, Zeng XT, et al. DHCR24 predicts poor clinicopathological features of patients with bladder cancer: a STROBE-compliant study. Medicine. 2018;97:e11830.","journal-title":"Medicine"},{"key":"3967_CR49","doi-asserted-by":"publisher","DOI":"10.1177\/15330338241259780","volume":"23","author":"X Fu","year":"2024","unstructured":"Fu X, Wang Z. DHCR24 in tumor diagnosis and treatment: a comprehensive review. Technol Cancer Res Treat. 2024;23:15330338241259780.","journal-title":"Technol Cancer Res Treat"},{"key":"3967_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1158\/0008-5472.CAN-20-2199","volume":"81","author":"JD Greenlee","year":"2021","unstructured":"Greenlee JD, Subramanian T, Liu K, King MR. Rafting down the metastatic cascade: the role of lipid rafts in cancer metastasis, cell death, and clinical outcomes. Cancer Res. 2021;81:5\u201317.","journal-title":"Cancer Res"},{"key":"3967_CR51","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.1074\/jbc.M806719200","volume":"284","author":"R Ramseger","year":"2009","unstructured":"Ramseger R, White R, Kroger S. Transmembrane form agrin-induced process formation requires lipid rafts and the activation of Fyn and MAPK. J Biol Chem. 2009;284:7697\u2013705.","journal-title":"J Biol Chem"},{"key":"3967_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05987-7","volume":"14","author":"R Xu","year":"2023","unstructured":"Xu R, Song J, Ruze R, Chen Y, Yin X, Wang C, et al. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src\/PI3K\/Akt signaling pathway. Cell Death Dis. 2023;14:497.","journal-title":"Cell Death Dis"},{"key":"3967_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13046-022-02261-0","volume":"41","author":"S Yu","year":"2022","unstructured":"Yu S, Wang L, Che D, Zhang M, Li M, Naito M, et al. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling. J Exp Clin Cancer Res. 2022;41:88.","journal-title":"J Exp Clin Cancer Res"},{"key":"3967_CR54","doi-asserted-by":"publisher","first-page":"32.","DOI":"10.3390\/cancers16010032","volume":"16","author":"L Raji","year":"2023","unstructured":"Raji L, Tetteh A, Amin A. Role of c-Src in carcinogenesis and drug resistance. Cancers. 2023;16:32.","journal-title":"Cancers"},{"key":"3967_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phrs.2015.01.003","volume":"94","author":"R Roskoski Jr","year":"2015","unstructured":"Roskoski R Jr. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors. Pharmacol Res. 2015;94:9\u201325.","journal-title":"Pharmacol Res"},{"key":"3967_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08306-4","volume":"17","author":"Y Tang","year":"2025","unstructured":"Tang Y, Deng X, Wang Y, Zhou Q, Zhang C, Liu Z, et al. NSUN2-mediated m5C modification of SOCS3 mRNA modulates macrophage polarization in bladder cancer. Cell Death Dis. 2025;17:75.","journal-title":"Cell Death Dis"},{"key":"3967_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07044-3","volume":"15","author":"WH Kao","year":"2024","unstructured":"Kao WH, Liao LZ, Chen YA, Lo UG, Pong RC, Hernandez E, et al. SPHK1 promotes bladder cancer metastasis via PD-L2\/c-Src\/FAK signaling cascade. Cell Death Dis. 2024;15:678.","journal-title":"Cell Death Dis"},{"key":"3967_CR58","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s42003-024-07284-1","volume":"8","author":"Y Gong","year":"2025","unstructured":"Gong Y, Gao D, Shi Y, Fan G, Yu X, Yang E, et al. SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway. Commun Biol. 2025;8:36.","journal-title":"Commun Biol"},{"key":"3967_CR59","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/j.asjsur.2024.01.094","volume":"47","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang J, Zhang G, Cai H. TFDP1 is a potential diagnostic, immunological and prognostic biomarker in pan-cancer. Asian J Surg. 2024;47:2481\u20133.","journal-title":"Asian J Surg"},{"key":"3967_CR60","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s41416-020-0758-1","volume":"122","author":"Y Morimoto","year":"2020","unstructured":"Morimoto Y, Mizushima T, Wu X, Okuzaki D, Yokoyama Y, Inoue A, et al. miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells. Br J Cancer. 2020;122:1037\u201349.","journal-title":"Br J Cancer"},{"key":"3967_CR61","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19:326\u201338.","journal-title":"Nat Rev Cancer"},{"key":"3967_CR62","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1172\/JCI81542","volume":"126","author":"PD Denechaud","year":"2016","unstructured":"Denechaud PD, Lopez-Mejia IC, Giralt A, Lai Q, Blanchet E, Delacuisine B, et al. E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis. J Clin Invest. 2016;126:137\u201350.","journal-title":"J Clin Invest"},{"key":"3967_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2021.05.012","volume":"514","author":"D Shen","year":"2021","unstructured":"Shen D, Gao Y, Huang Q, Xuan Y, Yao Y, Gu L, et al. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis. Cancer Lett. 2021;514:48\u201362.","journal-title":"Cancer Lett"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03967-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:03:33Z","timestamp":1791363813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03967-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":63,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2026,10,28]]}},"alternative-id":["3967"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03967-7","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods described in this study were performed in accordance with the relevant guidelines and regulations. All animal experiments conducted in this study were approved by the Animal Use and Care Committee of the Second Xiangya Hospital, Central South University (approval reference number: 20260742). The human tissue microarray (TMA) slides used in this study were commercially obtained from Bioaitech. The supplier confirmed that appropriate ethical approval was obtained and informed consent was provided by all participants prior to tissue collection. As this study did not involve direct interaction with human participants, additional informed consent for participation is not applicable. Furthermore, no identifiable images of human participants are included in this manuscript, and informed consent for the publication of such images is not required.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}